Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer

OncoTargets and Therapy ◽

10.2147/ott.s81837 ◽

2015 ◽

pp. 893

Author(s):

Zhehai Wang ◽

Qianqian Zhang ◽

jun Guo ◽

Liyan Liu ◽

Xiao Han ◽

...

Keyword(s):

Lung Cancer ◽

Targeted Therapy ◽

Small Cell Lung Cancer ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Single Agent Chemotherapy ◽

First Line Treatment

Download Full-text

42 10 year retrospective review of single agent chemotherapy as first line treatment in advanced non-small cell lung cancer (NSCLC) in Princess Margaret Hospital: Assessment of efficacy and prognostic factors

Lung Cancer ◽

10.1016/s0169-5002(13)70042-4 ◽

2013 ◽

Vol 79 ◽

pp. S14-S15

Author(s):

P. Martin ◽

C. Metran-Nascente ◽

S. Djalalov ◽

S. Lin ◽

N.B. Leighl

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Retrospective Review ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Single Agent Chemotherapy ◽

First Line Treatment

Download Full-text

Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital

Lung Cancer ◽

10.1016/s0169-5002(21)00241-5 ◽

2021 ◽

Vol 156 ◽

pp. S18

Author(s):

Rebecca Sen ◽

Rafiqul Islam Islam ◽

Harriet Baker ◽

Samuel Kim

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Single Agent ◽

University Hospital ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

6605 POSTER Oral vinorelbine as single-agent first-line treatment in elderly patients (pts) with advanced non-small-cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71433-7 ◽

2007 ◽

Vol 5 (4) ◽

pp. 389

Author(s):

M. Mendez ◽

J. Andrade ◽

G. Esquerdo ◽

S. Morales ◽

R. Garcia-Gomez ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

First Line Treatment

Download Full-text

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer – EORTC 08062

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.020 ◽

2011 ◽

Vol 47 (15) ◽

pp. 2322-2330 ◽

Author(s):

Mary E.R. O’Brien ◽

Krzystof Konopa ◽

Paul Lorigan ◽

Lionel Bosquee ◽

Ernest Marshall ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer

Medical Oncology ◽

10.1007/s12032-014-0420-y ◽

2014 ◽

Vol 32 (1) ◽

Author(s):

Zhixin Sheng ◽

Yanxia Zhang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Single Agent ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Tkis ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Line Treatment ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3454715 ◽

2019 ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Phase I Study ◽

Line Treatment ◽

Small Cell Lung ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.13462 ◽

2020 ◽

Author(s):

Po‐Lan Su ◽

Chian‐Wei Chen ◽

Yi‐Lin Wu ◽

Chien‐Chung Lin ◽

Wu‐Chou Su

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text